Head and Neck Cancer

Choosing Lymph Node Surgery Earlier May Be a Better Option for Some Patients with Oral Cancer

ASCO Annual Meeting
May 31, 2015

A new study provides clarification on the best time for patients to receive lymph node surgery for early-stage oral cancer. Oral cancer is often successfully treated with surgery to remove the tumor. However, the cancer can come back and spread to the lymph nodes in the neck.

Early Research Shows Potential of Pembrolizumab as Head and Neck Cancer Treatment

ASCO Annual Meeting
May 29, 2015

Results from a phase I clinical trial show that pembrolizumab (Keytruda) is able to shrink head and neck cancer that has spread to other parts of the body or come back after treatment. These findings suggest that immunotherapy may fill a large unmet need for better treatments for recurrent and advanced head and neck cancer.

Certain People with HPV-Positive Head and Neck Cancer May Benefit From a Lower Dose of Radiation Therapy

ASCO Annual Meeting
May 30, 2014

Early research suggests that lowering the dose of radiation therapy for some people with oropharyngeal cancer is an effective treatment option and may help reduce long-term side effects. This new approach customizes the radiation dose based on a person’s response to initial chemotherapy, as well as other factors known to affect a person’s chance of recovery, such as whether the tumor has tested positive for the human papillomavirus (HPV), the tumor’s size, and the person’s smoking history.

Subscribe to RSS - Head and Neck Cancer